# Treatment of Adult Patients With Hemoglobin SC Disease (SCYTHE)

> **NCT02640573** · PHASE2 · TERMINATED · sponsor: **Baylor College of Medicine** · enrollment: 1 (actual)

## Conditions studied

- Hemoglobin SC Disease

## Interventions

- **DRUG:** Hydroxyurea

## Key facts

- **NCT ID:** NCT02640573
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-10-12
- **Primary completion:** 2017-11-16
- **Final completion:** 2017-11-16
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Insufficient accrual
- **Last updated:** 2020-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02640573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02640573, "Treatment of Adult Patients With Hemoglobin SC Disease (SCYTHE)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02640573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*